FRM
ARRY

Fox Run Management’s Array Biopharma Inc ARRY Stock Holding History

Fox Run Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-31,397
Closed -$447K – 790
2018
Q4 		$447K Buy
+31,397
New +$476K 0.24% 142
2018
Q3 		– Sell
-22,491
Closed -$377K – 932
2018
Q2 		$377K Sell
22,491
-2,737
-11% -$43.5K 0.12% 349
2018
Q1 		$412K Buy
+25,228
New +$404K 0.1% 380
2017
Q4 		– Sell
-11,900
Closed -$146K – 984
2017
Q3 		$146K Buy
+11,900
New +$111K 0.04% 633
2017
Q2 		– Sell
-12,700
Closed -$114K – 908
2017
Q1 		$114K Buy
+12,700
New +$135K 0.05% 534

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fox Run Management's ARRY Position: Q1 2019 in Review

Fox Run Management sold out of Array Biopharma Inc (ARRY) in Q1 2019, closing a stake of 31,397 shares — an estimated $447K sold.

Fox Run Management first reported a position in ARRY in Q1 2017 and held it in 5 quarters. The position peaked at $447K in Q4 2018. 268 funds tracked by Wall St. Rank hold ARRY as of Q1 2019.

  • Fox Run Management reported no remaining Array Biopharma Inc position as of Q1 2019 after selling out during the quarter.
  • Fox Run Management sold 31,397 Array Biopharma Inc shares in Q1 2019, an estimated $447K.
  • Fox Run Management first reported a position in Array Biopharma Inc in Q1 2017 and held it in 5 quarters.
  • Fox Run Management's Array Biopharma Inc position peaked at $447K in Q4 2018.
  • 268 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2019.

Based on Fox Run Management's 13F filing for Q1 2019, filed 17 Oct 2019.